Published on in Vol 6, No 2 (2017): February

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Mara Buijs 1, MD;  Krijn P van Lienden 2, MD, PhD;  Peter GK Wagstaff 1, MD, PhD;  Matthijs JV Scheltema 1, MD;  Daniel M de Bruin 3, MSc, PhD;  Patricia J Zondervan 1, MD;  Otto M van Delden 2, MD, PhD;  Ton G van Leeuwen 3, MD, PhD;  Jean JMCH de la Rosette 1, MD, PhD;  M Pilar Laguna 1, MD, PhD

1 Academic Medical Center, Department of Urology, University of Amsterdam, Amsterdam , NL

2 Academic Medical Center, Department of Radiology, University of Amsterdam, Amsterdam , NL

3 Academic Medical Center, Department of Biomedical Engineering and Physics, University of Amsterdam, Amsterdam , NL

Corresponding Author:

  • Mara Buijs, MD
  • Academic Medical Center
  • Department of Urology
  • University of Amsterdam
  • Meibergdreef 9
  • Amsterdam
  • NL
  • Phone: 31 20 5665793
  • Email: m.buijs@amc.uva.nl